Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,496 | -520 | -888 | 18 | 4,656 |
| Depreciation Amortization | 1,911 | 1,502 | 1,030 | 523 | 1,992 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 542 |
| Accounts receivable | -2,499 | -2,697 | -1,133 | 353 | 1,705 |
| Accounts payable and accrued liabilities | -925 | 532 | -37 | -343 | 91 |
| Other Working Capital | -3,056 | -303 | -1,084 | -1,249 | -489 |
| Other Operating Activity | 5,174 | 3,559 | 2,074 | 522 | -1,568 |
| Operating Cash Flow | $-891 | $2,073 | $-38 | $-176 | $6,929 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,708 | -1,215 | -525 | -168 | -2,048 |
| Investing Cash Flow | $-1,708 | $-1,215 | $-525 | $-168 | $-2,048 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -238 | -179 | -118 | -59 | -245 |
| Common Stock Issued | 82 | 83 | 83 | N/A | 33 |
| Common Stock Repurchased | -22 | N/A | N/A | N/A | -8,509 |
| Dividend Paid | -28 | -21 | -14 | -7 | -28 |
| Financing Cash Flow | $-206 | $-117 | $-49 | $-66 | $-8,749 |
| Exchange Rate Effect | -56 | -56 | -20 | -51 | -85 |
| Beginning Cash Position | 16,762 | 16,762 | 16,762 | 16,762 | 20,715 |
| End Cash Position | 13,901 | 17,447 | 16,130 | 16,301 | 16,762 |
| Net Cash Flow | $-2,861 | $685 | $-632 | $-461 | $-3,953 |
| Free Cash Flow | |||||
| Operating Cash Flow | -891 | 2,073 | -38 | -176 | 6,929 |
| Capital Expenditure | -1,708 | -1,215 | -525 | -168 | -2,048 |
| Free Cash Flow | -2,599 | 858 | -563 | -344 | 4,881 |